Key result
High molecular weight dextran reduces blood flow less severely in working versus non-working muscle at ~45% of control.
Answers are grounded in this paper and cite their sources.
We studied the effect of high and low molecular weight dextran on blood flow and in vivo apparent viscosity in the vasodilated vascular bed of working and non-working skeletal muscle. In 12 mongrel dogs, the calf muscle of one hindlimb was isolated. Vasodilation was induced either by sciatic stimulation setting the muscle at rhythmic work or by intraarterial infusion of papaverine. Blood flow was measured electromagnetically at different perfusion pressures. In vivo apparent viscosity was calculated by comparing pressure-flow relationship for blood and a reference solution. Viscosity in vitro was determined in a cone-plate viscometer. A hyperviscous state was induced by intravenous infusion of high molecular weight dextran (HMWD). Hemodilution subsequently was produced by administration of low molecular weight dextran (LMWD). After HMWD, blood flow decreased to 30% of control values in the non-working group and to 45% of control values in the working group. After subsequent infusion of LMWD, blood flow returned to 60% of control values in the non-working group and to 70% of control values in the working group. In vivo apparent viscosity increased to values 250% above control in the non-working group and to 120% above control in the working group following HMWD. After subsequent infusion of LMWD in vivo, apparent viscosity decreased, but remained at values 65% above control in the non-working group and 45% above control in the working group. Thus, the flow impairment induced by HMWD was less pronounced in the working muscle, indicating a flow-preserving effect of rhythmic muscle contractions in this state of disturbed blood rheology. In contrast, the flow-improving effect of LMWD by hemodilution was more pronounced in the non-working muscle.
No takes yet. Share an insight, caveat, or question.
Gustafsson et al. (1981) studied Hyperviscosity and hemodilution in isolated skeletal muscle (n=12). High molecular weight dextran (HMWD) followed by low molecular weight dextran (LMWD) under working muscle conditions vs. Non-working muscle (vasodilated via intraarterial papaverine) was evaluated on Blood flow (% of control values) after HMWD infusion. High molecular weight dextran reduced blood flow to 45% of control in working muscle vs 30% in non-working muscle, which recovered to after low molecular weight dextran.
Synapse has enriched 10 related papers. Consider them for comparative context: